{
  "resourceType" : "ValueSet",
  "id" : "2.16.840.1.113883.3.464.1003.110.11.1107",
  "meta" : {
    "versionId" : "40",
    "lastUpdated" : "2023-12-21T17:43:03.000-05:00",
    "profile" : [
      "http://hl7.org/fhir/StructureDefinition/shareablevalueset",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
    ]
  },
  "extension" : [
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/valueset-author",
      "valueString" : "NCQA PHEMUR Author"
    },
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
      "valueDate" : "2024-02-12"
    },
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
      "valueDate" : "2023-02-11"
    }
  ],
  "url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.11.1107",
  "identifier" : [
    {
      "system" : "urn:ietf:rfc:3986",
      "value" : "urn:oid:2.16.840.1.113883.3.464.1003.110.11.1107"
    }
  ],
  "version" : "20230211",
  "name" : "VaricellaZosterVaccineVZVAdministered",
  "title" : "Varicella Zoster Vaccine (VZV) Administered",
  "status" : "active",
  "date" : "2023-02-11T01:02:55-05:00",
  "publisher" : "NCQA PHEMUR",
  "jurisdiction" : [
    {
      "coding" : [
        {
          "system" : "urn:iso:std:iso:3166",
          "code" : "US"
        }
      ]
    }
  ],
  "purpose" : "(Clinical Focus: The purpose of this value set is to represent concepts for a varicella zoster vaccination.),(Data Element Scope: This value set may use a model element related to Procedure.),(Inclusion Criteria: Includes concepts that represent a varicella zoster vaccination.),(Exclusion Criteria: No exclusions.)",
  "compose" : {
    "include" : [
      {
        "system" : "http://snomed.info/sct",
        "concept" : [
          {
            "code" : "425897001",
            "display" : "Administration of first dose of vaccine product containing only Human alphaherpesvirus 3 antigen for chickenpox (procedure)"
          },
          {
            "code" : "428502009",
            "display" : "Administration of second dose of vaccine product containing only Human alphaherpesvirus 3 antigen for chickenpox (procedure)"
          },
          {
            "code" : "432636005",
            "display" : "Administration of vaccine product containing only Human alphaherpesvirus 3 and Measles morbillivirus and Mumps orthorubulavirus and Rubella virus antigens (procedure)"
          },
          {
            "code" : "433733003",
            "display" : "Administration of second dose of vaccine product containing only Human alphaherpesvirus 3 and Measles morbillivirus and Mumps orthorubulavirus and Rubella virus antigens (procedure)"
          },
          {
            "code" : "572511000119105",
            "display" : "Administration of vaccine product containing only live attenuated Measles morbillivirus and Mumps orthorubulavirus and Rubella virus and Human alphaherpesvirus 3 antigens (procedure)"
          },
          {
            "code" : "737081007",
            "display" : "Administration of vaccine product containing only Human alphaherpesvirus 3 antigen for chickenpox (procedure)"
          },
          {
            "code" : "871898007",
            "display" : "Administration of vaccine product containing only live attenuated Human alphaherpesvirus 3 antigen (procedure)"
          },
          {
            "code" : "871899004",
            "display" : "Administration of vaccine product containing only live attenuated Human alphaherpesvirus 3 antigen via subcutaneous route (procedure)"
          },
          {
            "code" : "871909005",
            "display" : "Administration of first dose of vaccine product containing only Human alphaherpesvirus 3 and Measles morbillivirus and Mumps orthorubulavirus and Rubella virus antigens (procedure)"
          }
        ]
      }
    ]
  },
  "expansion" : {
    "identifier" : "urn:uuid:b61a97bd-7821-4d9c-899a-8f3c69e8944f",
    "timestamp" : "2024-06-14T16:47:24-04:00",
    "total" : 9,
    "contains" : [
      {
        "system" : "http://snomed.info/sct",
        "version" : "http://snomed.info/sct/731000124108/version/20240301",
        "code" : "425897001",
        "display" : "Administration of first dose of vaccine product containing only Human alphaherpesvirus 3 antigen for chickenpox (procedure)"
      },
      {
        "system" : "http://snomed.info/sct",
        "version" : "http://snomed.info/sct/731000124108/version/20240301",
        "code" : "428502009",
        "display" : "Administration of second dose of vaccine product containing only Human alphaherpesvirus 3 antigen for chickenpox (procedure)"
      },
      {
        "system" : "http://snomed.info/sct",
        "version" : "http://snomed.info/sct/731000124108/version/20240301",
        "code" : "432636005",
        "display" : "Administration of vaccine product containing only Human alphaherpesvirus 3 and Measles morbillivirus and Mumps orthorubulavirus and Rubella virus antigens (procedure)"
      },
      {
        "system" : "http://snomed.info/sct",
        "version" : "http://snomed.info/sct/731000124108/version/20240301",
        "code" : "433733003",
        "display" : "Administration of second dose of vaccine product containing only Human alphaherpesvirus 3 and Measles morbillivirus and Mumps orthorubulavirus and Rubella virus antigens (procedure)"
      },
      {
        "system" : "http://snomed.info/sct",
        "version" : "http://snomed.info/sct/731000124108/version/20240301",
        "code" : "572511000119105",
        "display" : "Administration of vaccine product containing only live attenuated Measles morbillivirus and Mumps orthorubulavirus and Rubella virus and Human alphaherpesvirus 3 antigens (procedure)"
      },
      {
        "system" : "http://snomed.info/sct",
        "version" : "http://snomed.info/sct/731000124108/version/20240301",
        "code" : "737081007",
        "display" : "Administration of vaccine product containing only Human alphaherpesvirus 3 antigen for chickenpox (procedure)"
      },
      {
        "system" : "http://snomed.info/sct",
        "version" : "http://snomed.info/sct/731000124108/version/20240301",
        "code" : "871898007",
        "display" : "Administration of vaccine product containing only live attenuated Human alphaherpesvirus 3 antigen (procedure)"
      },
      {
        "system" : "http://snomed.info/sct",
        "version" : "http://snomed.info/sct/731000124108/version/20240301",
        "code" : "871899004",
        "display" : "Administration of vaccine product containing only live attenuated Human alphaherpesvirus 3 antigen via subcutaneous route (procedure)"
      },
      {
        "system" : "http://snomed.info/sct",
        "version" : "http://snomed.info/sct/731000124108/version/20240301",
        "code" : "871909005",
        "display" : "Administration of first dose of vaccine product containing only Human alphaherpesvirus 3 and Measles morbillivirus and Mumps orthorubulavirus and Rubella virus antigens (procedure)"
      }
    ]
  }
}
